TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33962602

Group type: EXPERIMENTAL
Intervention: MySmileBuddy Program (MSB Program)
Number of subjects: 858

Group type: COMPARATOR
Intervention: Control Group (paper-based educational handout plus toothbrushes and fluoridated toothpaste for the child)
Number of subjects: 858
Study: 32622294

Group type: EXPERIMENTAL
Intervention: 10-week Hatha yoga programme
Number of subjects: 114

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 114

Group type: COMPARATOR
Intervention: Both groups (yoga and control)
Number of subjects: 114
Study: 35749253

Group type: EXPERIMENTAL
Intervention: Etelcalcetide plus active vitamin D (E+D group)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Etelcalcetide plus oral calcium (E+Ca group)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 124
Study: 32024491

Group type: EXPERIMENTAL
Intervention: Model of Goal Directed Behavior (MGDB) scales
Number of subjects: 186
Study: 35094139

Group type: EXPERIMENTAL
Intervention: Intervention Waiting Room (IWR) with music and visual objects
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intervention Waiting Room (IWR)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard Waiting Room (StWR)
Number of subjects: 104
Study: 34342134

Group type: EXPERIMENTAL
Intervention: Rectal spacer
Number of subjects: 20

Group type: COMPARATOR
Intervention: No rectal spacer
Number of subjects: 20
Study: 33883478

Group type: EXPERIMENTAL
Intervention: Intervention group (lifestyle modification program)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 269
Study: 33660429

Group type: EXPERIMENTAL
Intervention: Sandwich Model with PRS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lecture (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sandwich Model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PRS incorporation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-PRS activities
Number of subjects: 0
Study: 32185660

Group type: EXPERIMENTAL
Intervention: MAPS (Men and Providers Preventing Suicide) program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (sleep hygiene video plus brief non-tailored text)
Number of subjects: 48
Study: 32620259

Group type: EXPERIMENTAL
Intervention: Patient blood management (PBM) interventions
Number of subjects: 54917
Study: 33028693

Group type: EXPERIMENTAL
Intervention: APM score in NSCLC responders
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: APM score above median in NSCLC
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: APM score in NSCLC
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: APM score in high-risk resectable stage III/IV melanoma patients
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: APM score in metastatic melanoma patients
Number of subjects: 51
Study: 36229113

Group type: EXPERIMENTAL
Intervention: Behavioral Experiments for Intolerance of Uncertainty (12 weekly 1-hour sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 60
Study: 32943241

Group type: EXPERIMENTAL
Intervention: Specialized oral nutritional supplement (S-ONS)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 652
Study: 35421949

Group type: EXPERIMENTAL
Intervention: Focused Acceptance and Commitment Therapy (FACT-CP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 26
Study: 35233271

Group type: EXPERIMENTAL
Intervention: FES-cycling and standard treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham stimulus FES-cycling and standard treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 25
Study: 32071044

Group type: EXPERIMENTAL
Intervention: Ribavirin-PRINT-CFI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribavirin-PRINT-IP
Number of subjects: 0
Study: 35592817

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 89
Study: 33099752

Group type: EXPERIMENTAL
Intervention: Ropeginterferon alfa‐2b 350 μg (group 1)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Ropeginterferon alfa‐2b 450 μg (group 2)
Number of subjects: 62

Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2a 180 μg (group 3)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 62
Study: 34004418

Group type: EXPERIMENTAL
Intervention: Sulforaphane (30 mg/d)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36111547

Group type: EXPERIMENTAL
Intervention: Adherence Club (AC)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Routine PHC clinics (Control)
Number of subjects: 409
Study: 33963594

Group type: EXPERIMENTAL
Intervention: 8-week multimodal intervention (ATENTO) prior to adjuvant chemotherapy (ATENTO-B)
Number of subjects: 56

Group type: COMPARATOR
Intervention: 8-week multimodal intervention (ATENTO) throughout adjuvant chemotherapy (ATENTO-T)
Number of subjects: 56
Study: 35732186

Group type: EXPERIMENTAL
Intervention: RSV/ΔNS2/Δ1313/I1314L (106 PFU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RSV/276 (105 PFU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34556547

Group type: EXPERIMENTAL
Intervention: Link for Injured Kids (Link)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Trauma Education
Number of subjects: 314
Study: 32268973

Group type: EXPERIMENTAL
Intervention: Subarachnoid hemorrhage (SAH)
Number of subjects: 21600

Group type: EXPERIMENTAL
Intervention: Intracerebral hemorrhage (ICH)
Number of subjects: 21600
Study: 34763599

Group type: EXPERIMENTAL
Intervention: Heat-stable carbetocin 100 μg IM
Number of subjects: 1799

Group type: COMPARATOR
Intervention: Oxytocin 10 IU IM
Number of subjects: 1799
Study: 33196553

Group type: EXPERIMENTAL
Intervention: Heplisav-B
Number of subjects: 64
Study: 35719196

Group type: EXPERIMENTAL
Intervention: Neurodynamic technique (NT) with tendon gliding exercises (TGE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Carpal bone mobilization technique (CBMT) with tendon gliding exercises (TGE)
Number of subjects: 30
Study: 34933316

Group type: EXPERIMENTAL
Intervention: Chlorhexidine in 70% alcohol
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Povidone‐iodine in 70% alcohol
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Povidone‐iodine in aqueous solution
Number of subjects: 482
Study: 35476508

Group type: EXPERIMENTAL
Intervention: SBRT/nivolumab
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: SBRT/nivolumab/ipilimumab
Number of subjects: 84
Study: 32220595

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1 mg/mL solution in Mucolox (arm A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dexamethasone 0.1 mg/mL solution alone (arm B)
Number of subjects: 24
Study: 36301019

Group type: EXPERIMENTAL
Intervention: Fentanyl (25 µg) with 0.5% hyperbaric bupivacaine (3 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nalbuphine (0.8 mg) with 0.5% hyperbaric bupivacaine (3 mL)
Number of subjects: 60
Study: 33278844

Group type: EXPERIMENTAL
Intervention: Upper slope positions
Number of subjects: 179

Group type: COMPARATOR
Intervention: Lower slope positions
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Functional trait diversity
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Species identity and phylogeny
Number of subjects: 179
Study: 32185388

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS and 20 Hz rTMS
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 120
Study: 34627145

Group type: EXPERIMENTAL
Intervention: Invitation letter
Number of subjects: 3513

Group type: EXPERIMENTAL
Intervention: Phone call
Number of subjects: 3513

Group type: COMPARATOR
Intervention: SMS
Number of subjects: 3513

Group type: EXPERIMENTAL
Intervention: Invitation letter plus introduction video
Number of subjects: 3513

Group type: COMPARATOR
Intervention: Invitation letter only
Number of subjects: 3513
Study: 35707866

Group type: EXPERIMENTAL
Intervention: Oral tomato extract supplement containing lycopene 30 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 34835953

Group type: EXPERIMENTAL
Intervention: TLE (8 h eating/16 h fasting, 5 days per week) + blinded CGM
Number of subjects: 50

Group type: COMPARATOR
Intervention: Prolonged eating window (12 h eating/12 h fasting) + blinded CGM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TLE + real-time CGM feedback
Number of subjects: 50
Study: 32504272

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 45
Study: 35090517

Group type: EXPERIMENTAL
Intervention: Balance Exercise Assist Robot (BEAR) training combined with conventional inpatient rehabilitation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intensive balance training (IBT) combined with conventional inpatient rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional inpatient rehabilitation only (CR)
Number of subjects: 60
Study: 33689553

Group type: EXPERIMENTAL
Intervention: Audiobook Group (n = 12)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison Group (n = 8)
Number of subjects: 20
Study: 32329089

Group type: EXPERIMENTAL
Intervention: EMG biofeedback (BF) training during daytime, with feedback alert signals for excessive EMG activity
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (CO) with no feedback during EMG recording sessions
Number of subjects: 17
Study: 35344031

Group type: EXPERIMENTAL
Intervention: Transfusion of freshly irradiated RBCs
Number of subjects: 42

Group type: COMPARATOR
Intervention: Transfusion of irradiated and stored RBCs
Number of subjects: 42
Study: 33482896

Group type: EXPERIMENTAL
Intervention: Pathway-driven eHealth-based integrated care model (PEICM) with full access to the telehealth system.
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group using the mobile device only for BP measurement and receiving regular follow-ups.
Number of subjects: 402
Study: 32645144

Group type: EXPERIMENTAL
Intervention: Participation in aerosol-generating procedures (AGP)
Number of subjects: 4689

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 4689
Study: 34444764

Group type: EXPERIMENTAL
Intervention: Mangosteen and propolis extracts (MAEC) - daily intake of a single capsule containing 194 mg for eight weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Mangosteen and propolis extracts (MAEC)
Number of subjects: 104
Study: 33292205

Group type: EXPERIMENTAL
Intervention: Continuous care intervention (CCI) - very low carbohydrate diet inducing nutritional ketosis for 2 years
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Continuous care intervention (CCI)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Continuous care intervention (CCI) and usual care (UC)
Number of subjects: 194
Study: 35568270

Group type: EXPERIMENTAL
Intervention: Distanced self-talk
Number of subjects: 67

Group type: COMPARATOR
Intervention: Detached reappraisal
Number of subjects: 67
Study: 33258774

Group type: EXPERIMENTAL
Intervention: Super high-pressure balloon
Number of subjects: 74

Group type: COMPARATOR
Intervention: Scoring balloon
Number of subjects: 74
Study: 32252241

Group type: EXPERIMENTAL
Intervention: 600 IU/day vitamin D3
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D3
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 4000 IU/day vitamin D3
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 35960141

Group type: EXPERIMENTAL
Intervention: Acupuncture-only (group A)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Acupuncture with additional manual-movement or mind–body CIM therapies (group B)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard care (controls)
Number of subjects: 168
Study: 33794975

Group type: COMPARATOR
Intervention: No intervention (CON)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dietary intervention (DCON)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dietary intervention and supervised moderate volume exercise (MED)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dietary intervention and supervised high volume exercise (HED)
Number of subjects: 80
Study: 33156120

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 32576243

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Waiting list group
Number of subjects: 90
Study: 32412314

Group type: COMPARATOR
Intervention: 5% minoxidil twice daily for 24 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Microneedle therapy every 3 weeks for eight treatments
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Combination treatment of microneedling and 5% minoxidil for a total of 24 weeks
Number of subjects: 71
Study: 32186395

Group type: EXPERIMENTAL
Intervention: PPI + mucolytics
Number of subjects: 116

Group type: COMPARATOR
Intervention: PPI only
Number of subjects: 116
Study: 35332542

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)-based group counseling
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63
Study: 32157433

Group type: EXPERIMENTAL
Intervention: 177-lutetium DOTATATE (LuDO) molecular radiotherapy, 75 to 100 MBq kg-1 per course, up to four courses, spaced at 8- to 12-week intervals
Number of subjects: 21
Study: 35798520

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV23)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Experimental human pneumococcal challenge (EHPC)
Number of subjects: 100
Study: 33434956

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 33350366

Group type: EXPERIMENTAL
Intervention: Piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional long-lasting insecticidal nets (LLINs)
Number of subjects: 0
Study: 35964122

Group type: EXPERIMENTAL
Intervention: Open hemorrhoidectomy under local anesthesia
Number of subjects: 58

Group type: COMPARATOR
Intervention: Saddle block
Number of subjects: 58
Study: 34025683

Group type: EXPERIMENTAL
Intervention: Mastiha supplementation (2.1 g/day) for 6 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 32235883

Group type: EXPERIMENTAL
Intervention: Ad26, modified vaccinia Ankara vectors containing mosaic HIV‐1 antigens
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 35939114

Group type: EXPERIMENTAL
Intervention: Enhanced CT radiomics model (ERM)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Plain CT radiomics model (PRM)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Subjective image model (SIM)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Combined model (CM)
Number of subjects: 123
Study: 33471961

Group type: EXPERIMENTAL
Intervention: Higher milk and dairy products intake
Number of subjects: 6744

Group type: EXPERIMENTAL
Intervention: Lower milk consumption (<220 g/day)
Number of subjects: 6744

Group type: EXPERIMENTAL
Intervention: Fermented dairy products intake
Number of subjects: 6744

Group type: EXPERIMENTAL
Intervention: Whole milk consumption
Number of subjects: 6744
Study: 32627052

Group type: EXPERIMENTAL
Intervention: High flavanol (HF) chocolate bar (1060 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moderate flavanol (MF) chocolate bar (746 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low flavanol (LF) chocolate bar (406 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CON) chocolate bar (88 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All flavanol concentrations
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Higher flavanol concentrations
Number of subjects: 15
Study: 35974700

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (SWL)
Number of subjects: 613

Group type: COMPARATOR
Intervention: Ureteroscopic retrieval (URS)
Number of subjects: 613
Study: 32996156

Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum TMC3115
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 256
Study: 36380210

Group type: EXPERIMENTAL
Intervention: Spleen to non-cancerous liver volume ratio (STnLR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spleen volume
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spleen to liver volume ratio (STLR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspartate aminotransferase to platelet ratio index (APRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibrosis index based on the four factors (FIB-4)
Number of subjects: 0
Study: 32538286

Group type: EXPERIMENTAL
Intervention: Full body compression garment (FBCG) worn for 24 hours post-race
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no FBCG)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Full body compression garment (FBCG)
Number of subjects: 32
Study: 32541370

Group type: EXPERIMENTAL
Intervention: Citicoline eyedrops 3 times daily for 3 years
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo 3 times daily for 3 years
Number of subjects: 80
Study: 34859541

Group type: EXPERIMENTAL
Intervention: Medium intensity odours
Number of subjects: 22

Group type: COMPARATOR
Intervention: Odourless control stimulus
Number of subjects: 22
Study: 32367180

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m2, four weekly infusions)
Number of subjects: 59
Study: 34535609

Group type: EXPERIMENTAL
Intervention: Triamcinolone Acetonide (TAA)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Fluticasone Propionate (FP)
Number of subjects: 260
Study: 34196632

Group type: EXPERIMENTAL
Intervention: Multimedia Psychotherapy (with psycho-pharmacological therapy)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Psycho-pharmacological therapy and Multimedia Psychotherapy
Number of subjects: 36
Study: 35754298

Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and physician's choice chemotherapy (PTC)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Trastuzumab and physician's choice chemotherapy (TC)
Number of subjects: 219
Study: 34295147

Group type: EXPERIMENTAL
Intervention: Ranibizumab biosimilar
Number of subjects: 159

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 159
Study: 35164721

Group type: EXPERIMENTAL
Intervention: Youth-only arm (interactive age-tailored prevention program delivered in 10 weekly, 90-min sessions on self-care behaviors, media literacy, self-esteem, and positive body image)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Youth & parental component arm (includes the same youth program plus parental updates and shared assignments via WhatsApp or smartphone application)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: WhatsApp mode for parental updates and assignments
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Youth-only program delivered via smartphone application
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control group (received three health- and nutrition-related sessions)
Number of subjects: 418
Study: 34328695

Group type: EXPERIMENTAL
Intervention: Prone position ventilation (PPV)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Supine position ventilation (SPV)
Number of subjects: 80
Study: 32237292

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2550

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 2550

Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 2550

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2550

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 2550

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 2550

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 2550
Study: 35131154

Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vagus Nerve Isolation (VNI)
Number of subjects: 40
Study: 34222067

Group type: EXPERIMENTAL
Intervention: NEP (diabetes nutrition education program)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (education materials only)
Number of subjects: 77
Study: 32721104

Group type: EXPERIMENTAL
Intervention: Nicotinamide (1.5 g/day for 6 weeks, then 3.0 g/day for 6 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 34802729

Group type: EXPERIMENTAL
Intervention: Bupivacaine liposome suspension block, oral placebo (BUP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lidocaine block, oral placebo (LID)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lidocaine block, oral meloxicam (1 mg/kg of body weight; LID + MEL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline block, oral placebo (CON)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Saline block, oral placebo, sham dehorn (SHAM)
Number of subjects: 50
Study: 33055009

Group type: EXPERIMENTAL
Intervention: Health education program consisting of six educational sessions over 45 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine diabetic care at the clinic
Number of subjects: 80
Study: 33220141

Group type: EXPERIMENTAL
Intervention: Bonding agent (Adper™ Single Bond 2, 3M ESPE) applied before sealant application (Helioseal®clear, Ivoclar Vivadent)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nonbonded sealants
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Bonded and nonbonded sealants
Number of subjects: 98
Study: 33352676

Group type: EXPERIMENTAL
Intervention: Home-based resistance training (EXE)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 9